Holen Sie sich die Stockscreener-App
214.04
1.47%
3.11
Vorhandelsmarkt:
212.20
-1.84
-0.86%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$210.93
Offen:
$210.6
24-Stunden-Volumen:
1.76M
Relative Volume:
0.80
Marktkapitalisierung:
$50.85B
Einnahmen:
$234.31B
Nettoeinkommen (Verlust:
$1.61B
KGV:
32.31
EPS:
6.6243
Netto-Cashflow:
$4.45B
1W Leistung:
+1.74%
1M Leistung:
+2.76%
6M Leistung:
+36.21%
1J Leistung:
+63.73%
1-Tages-Spanne:
$210.01
$214.59
1-Wochen-Bereich:
$206.27
$214.59
52-Wochen-Spanne:
$120.72
$215.48
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Vergleichen Sie CAH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
214.04 | 50.12B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
MCK
Mckesson Corporation
|
834.18 | 102.03B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
356.14 | 69.16B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
HSIC
Henry Schein Inc
|
76.87 | 9.13B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.43 | 774.37M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Intact Investment Management Inc. Has $832,000 Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health (CAH) Laps the Stock Market: Here's Why - Yahoo Finance
Y Intercept Hong Kong Ltd Has $4.18 Million Stock Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Resona Asset Management Co. Ltd. Has $16 Million Position in Cardinal Health, Inc. $CAH - MarketBeat
UniSuper Management Pty Ltd Increases Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. (CAH) Stock Analysis: A Compelling 10.53% Upside Beckons Investors - directorstalkinterviews.com
Cardinal Health, Inc. $CAH Shares Sold by Sector Gamma AS - MarketBeat
Cardinal Health, Inc. $CAH Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Cardinal Health, Inc. $CAH Shares Sold by AMF Tjanstepension AB - MarketBeat
Argus Issues Positive Forecast for Cardinal Health (NYSE:CAH) Stock Price - MarketBeat
With EPS Growth And More, Cardinal Health (NYSE:CAH) Makes An Interesting Case - Yahoo Finance
Teacher Retirement System of Texas Raises Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health (NYSE:CAH) Rating Increased to Strong-Buy at Argus - MarketBeat
Cardinal Health Expands Rapiblyk Access And Deepens Critical Care Ties - Sahm
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Agios Pharma (AGIO) and Henry Schein (HSIC) - The Globe and Mail
Cardinal Health Upgraded As It Maintains Investment-Grade Status And Position In Radiopharmaceuticals - Seeking Alpha
Highlighting Strategic Progress in Fiscal Year 2026 at the J.P. Morgan Healthcare Conference - Cardinal Health
Universal Beteiligungs und Servicegesellschaft mbH Lowers Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Rakuten Investment Management Inc. Makes New $6.98 Million Investment in Cardinal Health, Inc. $CAH - MarketBeat
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology - The Globe and Mail
Bailard Inc. Purchases 6,476 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Vest Financial LLC Trims Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Allstate Corp Acquires New Position in Cardinal Health, Inc. $CAH - MarketBeat
Investors in Cardinal Health (NYSE:CAH) have seen massive returns of 332% over the past five years - Yahoo Finance
Cardinal Health, Inc. (CAH) shares gain favor as Citi turns bullish on specialist assets - MSN
QRG Capital Management Inc. Decreases Holdings in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. $CAH Shares Sold by Campbell & CO Investment Adviser LLC - MarketBeat
Cardinal Health, Inc. (CAH) Stock Analysis: Navigating the Healthcare Giant’s 6.82% Potential Upside - DirectorsTalk Interviews
Cardinal Health, Inc. (NYSE:CAH) Sees Large Growth in Short Interest - MarketBeat
Nippon Life Global Investors Americas Inc. Trims Stake in Cardinal Health, Inc. $CAH - MarketBeat
Jim Cramer says “Cardinal is really the monster” among drug distributors - MSN
Cardinal Health Upgraded to Buy by Citi, Price Target Raised to $244 - Intellectia AI
Cardinal Health, Inc. (CAH) Shares Gain Favor as Citi Turns Bullish on Specialist Assets - Yahoo Finance
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue? - sharewise.com
Cardinal Health (CAH) Valuation Check After Strong Recent Share Price Momentum - Sahm
Cardinal Health raises FY26 outlook above consensus - MSN
Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue - Yahoo Finance
Procyon Advisors LLC Makes New Investment in Cardinal Health, Inc. $CAH - MarketBeat
Nordea Investment Management AB Increases Stake in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. $CAH Stake Reduced by Cairn Investment Group Inc. - MarketBeat
Lobbying Update: $60,000 of CARDINAL HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Buyback Watch: What is the earnings history of Cardinal Health IncGlobal Markets & Weekly High Return Stock Forecasts - baoquankhu1.vn
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report? - Finviz
Cardinal Health (NYSE:CAH) Sets New 1-Year High on Analyst Upgrade - MarketBeat
Wells Fargo & Company Issues Positive Forecast for Cardinal Health (NYSE:CAH) Stock Price - MarketBeat
Wells Fargo Raises Price Target for Cardinal Health (CAH) to $23 - GuruFocus
Cardinal Health stock reaches all-time high at $214.93 By Investing.com - Investing.com Canada
Assessing Cardinal Health (CAH) After A 73% One Year Share Price Surge - Sahm
Cardinal Health (NYSE:CAH) S&P 500 ETF Healthcare Infrastructure - Kalkine Media
Cardinal Health boosts profit forecast to $10/share, expands Publix deal - The Business Journals
Cardinal Health introduces ContinuCare™ Pathway; announces relationship with Publix - WebWire
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):